Belfast man's firm Diaceutics teams up with top technology giants to boost research
A firm founded by a Belfast man is teaming up with two top tech giants as part of its latest expansion.
Peter Keeling's Diaceutics, which now boasts turnover of around $10m (£7.5m), has industry leaders like GSK and Diagnology among its clients.
It has now announced a collaboration with computer hardware manufacturer Lenovo, and chip manufacturer Intel.
Mr Keeling said: "Artificial intelligence can make a very strong and positive impact on precision medicine and we are excited to be moving the boundaries with this highly innovative technology.
"We can now look at data in a novel way. No longer will we only be making decisions based on diagnostic data.
"Artificial intelligence allows us to look at the complete patient journey from initial testing and diagnosis, and on to the ultimate treatment. The result will be significantly better patient testing and likely improved patient outcomes, such as longer cancer survivorship rates.
"This collaboration is a major step in our mission to help patients, by helping them find the right precision medicine at the right time.
"We are using artificial intelligence to enable the world to unlock the true life-changing promise of precision medicine."